References
- BennettSRFolkJCKimuraAERussellSRStoneEMRaphtisEMAutosomal dominant neovascular inflammatory vitreoretinopathyOphthalmology199097911251135 discussion 1126–11352234842
- MahajanVBSkeieJMBassukAGCalpain-5 mutations cause autoimmune uveitis, retinal neovascularization, and photoreceptor degenerationPLoS Genet2012810e100300123055945
- BassukAGYehSWuSStructural modeling of a novel CAPN5 mutation that causes uveitis and neovascular retinal detachmentPLoS One2015104e012235225856303
- WertKJBassukAGWuWHCAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse modelHum Mol Genet201524164584459825994508
- SiddiqueSSSuelvesAMBahetiUFosterCSGlaucoma and uveitisSurv Ophthalmol201358111023217584
- SungVCBartonKManagement of inflammatory glaucomasCurr Opin Ophthalmol200415213614015021226
- TlucekPSFolkJCSobolWMMahajanVBSurgical management of fibrotic encapsulation of the fluocinolone acetonide implant in CAPN5-associated proliferative vitreoretinopathyClin Ophthalmol201371093109823785231
- MalonePEHerndonLWMuirKWJaffeGJCombined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucomaAm J Ophthalmol20101495800806.e120189158
- AhmadZMHughesBAAbramsGWMahmoudTHCombined posterior chamber intraocular lens, vitrectomy, Retisert, and pars plana tube in noninfectious uveitisArch Ophthalmol2012130790891322776928
- TlucekPSFolkJCOrienJAStoneEMMahajanVBInhibition of neovascularization but not fibrosis with the fluocinolone acetonide implant in autosomal dominant neovascular inflammatory vitreoretinopathyArch Ophthalmol2012130111395140122777573
- KocaboraMSYilmazliCTaskapiliMGulkilikGDurmazSDevelopment of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinoloneClin Ophthalmol20082116717119668401
- RowellHABassukAGMahajanVBMonozygotic twins with CAPN5 autosomal dominant neovascular inflammatory vitreoretinopathyClin Ophthalmol201262037204423271883
- FriedmanDSHolbrookJTAnsariHRisk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trialOphthalmology201312081571157923601801
- BollingerKESmithSDPrevalence and management of elevated intraocular pressure after placement of an intravitreal sustained-release steroid implantCurr Opin Ophthalmol20092029910319248312
- BollingerKKimJLowderCYKaiserPKSmithSDIntraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitisOphthalmology2011118101927193121652079
- SanisloSRLowderCYKaiserPKCorticosteroid therapy for optic disc neovascularization secondary to chronic uveitisAm J Ophthalmol2000130672473111124290
- Da MataABurkSENetlandPABaltatzisSChristenWFosterCSManagement of uveitic glaucoma with Ahmed glaucoma valve implantationOphthalmology1999106112168217210571354
- HuangMCNetlandPAColemanALSiegnerSWMosterMRHillRAIntermediate-term clinical experience with the Ahmed glaucoma valve implantAm J Ophthalmol1999127127339932995
- AlvaradoJAHollanderDAJusterRPLeeLCAhmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomesAm J Ophthalmol2008146227628418538300
- MincklerDSFrancisBAHodappEAAqueous shunts in glaucoma: a report by the American Academy of OphthalmologyOphthalmology200811561089109818519069